Related Experiment Video

Updated: Jun 27, 2025

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

83

PTEN: an emerging target in rheumatoid arthritis?

Pan Zhou1, Xingwen Meng1, Zhimin Nie1

  • 1Chengdu Rheumatology Hospital, Chengdu, Sichuan Province, China.

Cell Communication and Signaling : CCS
|April 26, 2024
PubMed

Insights

Phosphatase and tensin homolog (PTEN) loss promotes rheumatoid arthritis (RA) by enhancing fibroblast-like synoviocyte survival and osteoclast activity. Restoring PTEN may mitigate RA-associated joint damage.

Area of Science:

  • Molecular Biology
  • Immunology
  • Rheumatology

Background:

  • PTEN is a tumor suppressor regulating cell processes via the PI3K/AKT pathway.
  • PTEN dysfunction is implicated in rheumatoid arthritis (RA) pathogenesis.
  • Reduced PTEN expression in RA synovial lining correlates with aggressive disease.

Purpose of the Study:

  • To elucidate the role of aberrant PTEN signaling in RA progression.
  • To understand PTEN's interactions with other molecules in RA.
  • To provide theoretical support for RA research and treatment.

Main Methods:

  • Literature review of PTEN's function in cellular processes.
  • Analysis of PTEN expression in RA synovial tissues.
  • Review of studies on PI3K/AKT pathway dysregulation in RA.

Main Results:

  • PTEN loss promotes fibroblast-like synoviocyte (FLS) survival and proliferation.
  • Aberrant PI3K signaling due to PTEN loss enhances myeloid cell osteoclastogenesis.
  • Minimal PTEN expression is observed in aggressive RA FLS.

Conclusions:

  • PTEN dysregulation is a key driver of RA pathogenesis.
  • Targeting PTEN may offer a therapeutic strategy for RA.
  • Further research is needed to fully understand PTEN's complex role in RA.
Keywords:
Fibroblast-like synoviocytePI3K/AKTPTENRheumatoid arthritisTarget

More Related Videos

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

126
Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice04:47

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice

Published on: October 27, 2023

952

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.8K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.4K